Macrophages induce COX-2 expression in breast cancer cells: Role of IL-1β autoamplification

Carcinogenesis

Volumn 32, Issue 5, 2011, Pages 695-702

  Hou, Zhe ^a   Falcone, Domenick J ^a   Subbaramaiah, Kotha ^a   Dannenberg, Andrew J ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE; OXIDOREDUCTASE INHIBITOR; PROSTAGLANDIN E2; PROTEIN P67; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; CANCER CELL; CELL EXPANSION; COCULTURE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MACROPHAGE; MOUSE; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 79955771440     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgr027     Document Type: Article

References (57)

1. Lewis,C.E. et al. (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res., 66, 605-612.
2. Mantovani,A. et al. (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol., 23, 549-555.
3. Leek,R.D. et al. (2002) Tumor-associated macrophages in breast cancer. J. Mammary Gland Biol. Neoplasia, 7, 177-189.
4. Leek,R.D. et al. (1996) Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res., 56, 4625-4629.
5. DeNardo,D.G. et al. (2009) CD4(+) T cells regulate pulmonary metastasis of mammary carcinomas by enhancing protumor properties of macrophages. Cancer Cell, 16, 91-102.
6. Hagemann,T. et al. (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis, 25, 1543-1549.
7. Goswami,S. et al. (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res., 65, 5278-5283.
8. Singh-Ranger,G. et al. (2008) The role of cyclooxygenase-2 in breast cancer: review. Breast Cancer Res.Treat., 109, 189-198.
9. Howe,L.R. (2007) Inflammation and breast cancer. Cyclooxygenase/prostaglandin signaling and breast cancer. Breast Cancer Res., 9, 210.
10. Nakatsugi,S. et al. (2000) Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats. Jpn. J. Cancer Res., 91, 886-892.
11. Harris,R.E. et al. (2000) Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor. Cancer Res., 60, 2101-2103.
12. Howe,L.R. et al. (2005) HER2/neu-induced mammary tumorigenesis and angiogenesis are reduced in cyclooxygenase-2 knockout mice. Cancer Res., 65, 10113-10119.
13. Cotterchio,M. et al. (2001) Nonsteroidal anti-inflammatory drug use and breast cancer risk. Cancer Epidemiol. Biomarkers Prev., 10, 1213-1217.
14. Khuder,S.A. et al. (2001) Breast cancer and NSAID use: a meta-analysis. Br. J. Cancer, 84, 1188-1192.
15. Gazdar,A.F. et al. (1998) Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer. Int. J. Cancer, 78, 766-774.
16. Soule,H.D. et al. (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J. Natl Cancer Inst., 51, 1409-1416.
17. Trempe,G.L. (1976) Human breast cancer in culture. Recent Results Cancer Res., 57, 33-41.
18. Tsuchiya,S. et al. (1980) Establishment and characterization of a human acute leukemia cell line (THP-1). Int. J. Cancer, 26, 171-176.
19. Rigby,C.C. et al. (1970) A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure. Br. J. Cancer., 24, 746-754.
20. Raschke,W.C. et al. (1978) Functional macrophage cell lines transformed by Abelson leukemia virus. Cell, 15, 261-267.
21. Telang,N.T. et al. (1991) Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells. Breast Cancer Res.Treat., 18, 155-163.
22. Muller,W.A. et al. (1992) Monocyte-selective transmigration: dissection of the binding and transmigration phases by and in vitro assay. J. Exp. Med., 176, 819-828.
23. Khan,K.M.F. et al. (2004) Extracellular matrix-induced cyclooxygenase-2 regulates macrophage proteinase expression. J. Biol. Chem., 279, 22039-22046.
24. Subbaramaiah,K. et al. (2002) Cyclooxygenase-2 is overexpressed in HER-2/neu-positive breast cancer - evidence for involvement of AP-1 and PEA3. J. Biol. Chem., 277, 18649-18657.
25. Zar,J.H. (1984) Biostatistical Analysis. Prentice Hall, Englewood Cliffs, NJ.
26. Kim,E.H. et al. (2008) 15-Deoxy-delta12,14-prostaglandin J2 induces COX-2 expression through Akt-driven AP-1 activation in human breast cancer cells: a potential role of ROS. Carcinogenesis, 29, 688-695.
27. Grau,R. et al. (2004) Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism. Cancer Res., 64, 5162-5171.
28. Chen,J.J. et al. (2005) Transcriptional regulation of cyclooxygenase-2 in response to proteasome inhibitors involves reactive oxygen speciesmediated signaling pathway and recruitment of CCAAT/enhancerbinding protein delta and CREB-binding protein. Mol. Biol. Cell, 16, 5579-5591.
29. Rosado,J.A. et al. (2004) Hydrogen peroxide generation induces pp60src activation in human platelets: evidence for the involvement of this pathway in store-mediated calcium entry. J. Biol. Chem., 279, 1665-1675.
30. Giannoni,E. et al. (2005) Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchorage-dependent cell growth. Mol. Cell. Biol., 25, 6391-6403.
31. Matsuura,H. et al. (1999) Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells - Role of mitogen-activated protein kinases. J. Biol. Chem., 274, 29138-29148.
32. Mehdi,M.Z. et al. (2005) H2O2-induced phosphorylation of ERK1/2 and PKB requires tyrosine kinase activity of insulin receptor and c-Src. Antioxid. Redox Signal., 7, 1014-1020.
33. Bachelor,M.A. et al. (2004) UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression. Semin. Cancer Biol., 14, 131-138.
34. Roy,D. et al. (2006) Levels of IL-1 beta control stimulatory/inhibitory growth of cancer cells. Front. Biosci., 11, 889-898.
35. Li,Q. et al. (2006) Nox2 and Rac1 regulate H2O2-dependent recruitment of TRAF6 to endosomal interleukin-1 receptor complexes. Mol. Cell. Biol., 26, 140-154.
36. Chen,W.T. et al. (2009) Overexpression of cyclooxygenase-2 in urothelial carcinoma in conjunction with tumor-associated-macrophage infiltration, hypoxia-inducible factor-1alpha expression, and tumor angiogenesis. APMIS, 117, 176-184.
37. Dinarello,C.A. et al. (1987) Interleukin 1 induces interleukin 1. I. Induction of circulating interleukin 1 in rabbits in vivo and in human mononuclear cells in vitro. J. Immunol., 139, 1902-1910.
38. Jin,L. et al. (1997) Expression of interleukin-1beta in human breast carcinoma. Cancer, 80, 421-434.
39. Grimm,C. et al. (2009) The prognostic value of four interleukin-1 gene polymorphisms in Caucasian women with breast cancer: a multicenter study. BMC Cancer, 9, 78.
40. Voronov,E. et al. (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl Acad. Sci. USA., 100, 2645-2650.
41. Reed,J.R. et al. (2009) Interleukin-1beta and fibroblast growth factor receptor 1 cooperate to induce cyclooxygenase-2 during early mammary tumourigenesis. Breast Cancer Res., 11, R21.
42. Li,Q. et al. (2008) Endosomal NADPH oxidase regulates c-Src activation following hypoxia/reoxygenation injury. Biochem. J., 411, 531-541.
43. Subbaramaiah,K. et al. (2000) Microtubule-interfering agents stimulate the transcription of cyclooxygenase-2-Evidence for involvement of ERK1/2 and p38 mitogen-activated protein kinase pathways. J. Biol. Chem., 275, 14838-14845.
44. Subbaramaiah,K. et al. (1998) Ceramide regulates the transcription of cyclooxygenase-2-evidence for involvement of extracellular signalregulated kinase c-Jun N-terminal kinase and p38 mitogen-activated protein kinase pathways. J. Biol. Chem., 273, 32943-32949.
45. Subbaramaiah,K. et al. (2003) Regulation of cyclooxgenase-2 mRNA stability by taxanes - evidence for involvement of p38, MAPKAPK-2, and HuR. J. Biol. Chem., 278, 37637-37647.
46. Subbaramaiah,K. et al. (2002) Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein/p300-dependent and -independent mechanisms. Cancer Res., 62, 2522-2530.
47. Bunt,S.K. et al. (2006) Inflammation induces myeloid-derived suppressor cells that facilitate tumor progression. J. Immunol., 176, 284-290.
48. Sinha,P. et al. (2007) Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res., 67, 4507-4513.
49. Mosser,D.M. et al. (2008) Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol., 8, 958-969.
50. Martinez,F.O. et al. (2008) Macrophage activation and polarization. Front. Biosci., 13, 453-461.
51. Sica,A. et al. (2008) Macrophage polarization in tumour progression. Semin. Cancer Biol., 18, 349-355.
52. Van Ginderachter,J.A. et al. (2006) Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology, 211, 487-501.
53. Tjiu,J.W. et al. (2009) Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J. Invest. Dermatol., 129, 1016-1025.
54. Marcinkiewicz,J. (1991) In vitro cytokine release by activated murine peritoneal macrophages: role of prostaglandins in the differential regulation of tumor necrosis factor alpha, interleukin 1, and interleukin 6. Cytokine, 3, 327-332.
55. Cook,A.D. et al. (2003) The phenotype of inflammatory macrophages is stimulus dependent: implications for the nature of the inflammatory response. J. Immunol., 171, 4816-4823.
56. Arun,B. et al. (2004) The role of COX-2 inhibition in breast cancer treatment and prevention. Semin. Oncol., 31, 22-29.
57. Saad,F. et al. (2010) SRC kinase inhibition: targeting bone metastases and tumor growth in prostate and breast cancer. Cancer Treat. Rev., 36, 177-184.